Submit your Bextra claim details for a free, no obligation case review
Get Started:
A Bextra claim is a civil lawsuit that is filed on behalf of a party who has been injured as a result of Bextra side effects. A Bextra claim can be filed by one individual who seeks compensation for Bextra-related loses, or a Bextra claim can be filed on behalf of a group of individuals who have been injured as a result of Bextra use. The latter is known as a class action lawsuit, while the former is an individual lawsuit. There are benefits and drawbacks to both of these Bextra claim options, which can be discussed in greater detail with a legal professional.
A Bextra claim is a viable legal option for those who seek compensation for their Bextra related injuries. Bextra is a COX-2 selective non-steroidal anti-inflammatory drug (NSAID) that was approved by the FDA in November 2001. Since Pfizer introduced Bextra on the US drug market, there have been numerous reports of serious side effects associated with this drug. Pfizer has consistently maintained that their top selling pain reliever is safe for consumer use, despite findings to the contrary.
A Bextra claim is a legal option for those who have suffered a serious cardiovascular or skin-related adverse drug reaction. Bextra has been known to cause rare, but life threatening, skin conditions such as toxic epidermal necrolysis and Stevens-Johnson syndrome. These rapidly progressive conditions are characterized by extensive skin and mucous membrane destruction which can lead to fatal complications if not properly treated.
A Bextra claim may also be appropriate for those who have suffered a Bextra-related cardiovascular injury like a heart attack or stroke. Concern about Bextra’s cardiovascular safety first began after the recall of a similar drug called Vioxx in September 2004. This drug doubled a patient’s risk of suffering a heart attack or stroke. Pfizer consistently maintained that these side effects were unique to Vioxx and that Bextra did not pose a similar threat. In December 2004 Pfizer released the results of a study that found an increased risk of cardiovascular complications in patients taking Bextra.
Due to the mounting evidence of Bextra’s dangers, the FDA urged Pfizer to pull Bextra off the shelves in April 2005. Bextra was officially pulled from the market on April 7, 2005 in both Europe and the United States. The FDA ordered this recall after extensive studies concluded that the risks associated with Bextra far outweighed its potential benefits. Even after this recall, Pfizer stated that it would look for ways to possibly resume sales of this drug.
A Bextra claim is valid under the strict liability principle of personal injury law. This states that manufacturers of a defective drug can be held liable for the damages caused by their product, particularly when the company negligently fails to protect or inform consumers of these risks. A Bextra claim may also be possible for those who have not been injured by Bextra, but who seek medical monitoring as a preventative and early detection measure. If you or a loved one has taken Bextra, you may wish to contact a qualified attorney who can determine if you are eligible for a Bextra claim.
Bextra , the popular cox-2 inhibitor recalled by Pfizer, is the subject of another lawsuit.
Rita Fohne has filed her lawsuit against Pfizer in Madison County, Illinois, seeking ...
The U.S. Food and Drug Administration has started issuing alerts to patients and doctors on its new site Drug Watch. Including emerging drug-safety concerns, as well as dangers presented by drugs prescribed for unapproved uses, the new site is in resp...
After a controversial year of drug recalls, the FDA was under attack for failing to adequately protect consumers from dangerous drugs. Currently, the FDA has the Adverse Event Reporting System, or AERS, to collect voluntary reports of possible reactio...
Copyright © 2001 - 2010 Online Lawyer Source | Legal Marketing Site Designed by eJustice